Phase 2 clinical trial indicates that AC6 gene transfer -- also known as RT-100 -- safely increases function of the failing heart SAN DIEGO, Calif., March 30, 2016 - Renova™ Therapeutics, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback